Asphalion has signed an agreement to be part of Barcelona Health Hub, the non-profit organization oriented to the development of companies and organizations working in the field of digital health in order to enhance innovation.
In the words of Ricard Sagués, Business Development & Marketing Director at Asphalion: “New technologies are a key element of digital transformation in the healthcare sector. Joining Barcelona Health Hub will allow us to bring our knowledge in the regulatory field to any project and, as a result, make it possible for innovative solutions to reach patients sooner and better.”
Dominique Monferrer, Medical Device Director at Asphalion, says: “Medical Technology will generate much of the future innovation in healthcare and must be integrated into an increasingly demanding regulatory environment with major changes. New software, new materials, new drug delivery systems and new biomarkers are some of the areas with the greatest development potential.”
Asphalion is an international Scientific and Regulatory Affairs consultancy company with offices in Barcelona, Madrid, Munich, Amsterdam and London. Founded in 2000, it has consistently grown, and now employs more than 100 team members from 12 different nationalities with backgrounds in Pharmacy, Chemistry, Biology, Biochemistry, Biotechnology and Medicine. Asphalion collaborates with Pharmaceutical, Biotechnological and Medical Technology organizations facilitating product development and regulatory affairs solutions for their projects.